SURVODUTIDE 10MG

========================
SURVODUTIDE — Research Dual Agonist (GLP-1R/GCGR)
========================
Class: Incretin + glucagon receptor co-agonist; metabolic research

Research Focus (non-clinical):
• Appetite/satiety + energy-expenditure coupling (dual-pathway mapping)
• Hepatic fatty-acid oxidation and steatosis markers
• Comparative profiling vs. single-pathway incretins/poly-agonists

Notes for Investigators:
Referenced as a dual-agonist tool for studying coordinated weight-energy dynamics and liver fat endpoints in models. :contentReference[oaicite:21]{index=21} :contentReference[oaicite:22]{index=22}

Regulatory & Use
• Laboratory research only. Not for human or veterinary use. :contentReference[oaicite:23]{index=23}